Report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. Clin Transpl 1993:101-8
Date
01/01/1993Pubmed ID
7918143Scopus ID
2-s2.0-0027792006 (requires institutional sign-in at Scopus site) 6 CitationsAbstract
The Statistical Center of the IBMTR/NAABMTR has expanded its role from collecting data on allogeneic and syngeneic transplants to the area of autologous bone marrow and blood cell transplantation given to support high-dose therapies for cancer. In diseases such as acute leukemia for which both allogeneic and autotransplants are performed, direct comparisons of outcomes of these therapies are now possible. The large number of cases that has accrued rapidly into the NAABMTR (over 9,000 since 1989) will allow us to use sophisticated statistical techniques to determine potential benefits and disadvantages in the rapidly growing area of autotransplantation.
Author List
Rowlings PA, Horowitz MM, Armitage JO, Gale RP, Sobocinski KA, Zhang MJ, Bortin MMAuthors
Mary M. Horowitz MD, MS Professor in the Medicine department at Medical College of WisconsinMei-Jie Zhang PhD Professor in the Institute for Health and Equity department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AsiaBone Marrow Transplantation
Europe
Female
Humans
Leukemia
Male
North America
Registries
Transplantation, Autologous
